Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC72987N-Acetyl-D-galactosamine, 98%CAS: 14215-68-0纯度: >98.00%
N-Acetyl-D-galactosamine, 98%(GalNAc)是一种末端必需氨基糖,来源于半乳糖,形成人类血型a的抗原。
- GC73098STING agonist-17CAS: 2816929-47-0纯度: >96.00%
STING agonist-17(化合物4a)是一种有效的STING激动剂,IC50值为0.062 nM。
- GC73106Cemdisiran sodium纯度: >96.00%
Cemdisiran sodium是一种N-乙酰半乳糖胺(GalNAc)偶联的siRNA,用于通过抑制肝脏产生补体5(C5)蛋白来研究补体介导的疾病。
- GC73129SIAIS164018 hydrochloride纯度: >99.00%
SIAIS164018 hydrochloride是一种基于protac的ALK和EGFR降解剂,ALK和ALK G1202R的IC50值分别为2.5 nM和6.6 nM。
- GC73135Glu-urea-Glu-NHS esterCAS: 1228927-36-3纯度: >97.00%
Glu-urea-Glu-NHS ester是Glu-尿素-Glu的活化N-羟基琥珀酰胺(NHS)酯,可用作与前列腺特异性膜抗原(PSMA)抑制剂连接的药效团。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC72948 | Dibenzo(a,i)pyrene | 189-55-9 | >98.00% | |
Dibenzo(a,i)pyrene是2,3,7,8-四氯二苯并-对二恶英TCDD受体配体。 | ||||
| GC72956 | Batifiban TFA | - | >99.00% | |
Batifiban TFA环肽是血小板糖蛋白GPⅡb/Ⅲa的拮抗剂,可抑制血小板聚集。 | ||||
| GC72971 | INCB3619 | 791826-72-7 | >99.00% | |
INCB3619ADAM10和ADAM17的IC50分别为22nM和14nM。 | ||||
| GC72984 | FAPI-2 TFA | - | >98.00% | |
FAPI-2 TFA是一种成纤维细胞活化蛋白(FAP)抑制剂,在癌症研究中有潜在的用途。 | ||||
| GC72985 | Z-LEVD-FMK | 1135688-25-3 | >98.00% | |
Z-LEVD-FMK是一种细胞渗透性caspase-4抑制剂。 | ||||
| GC72987 | N-Acetyl-D-galactosamine, 98% | 14215-68-0 | >98.00% | |
N-Acetyl-D-galactosamine, 98%(GalNAc)是一种末端必需氨基糖,来源于半乳糖,形成人类血型a的抗原。 | ||||
| GC72994 | RAPTA-C | 372948-28-2 | >99.00% | |
RAPTA-C (Ru(η - 6-p-cymene)Cl2(pta))是一种抗癌和抗血管生成剂。 | ||||
| GC72995 | MnTE-2-PyP chloride | 219818-60-7 | >95.00% | |
MnTE-2-PyP chloride是活性氧清除剂和有效的放射性保护剂。 | ||||
| GC73002 | Ganglioside GD3 diammonium | - | >98.00% | |
Ganglioside GD3 diammonium是一种酸性鞘糖脂。 | ||||
| GC73016 | AZD4877 | 758722-49-5 | >98.00% | |
AZD4877是Ispinesib的另一种同分异构体,也是一种激酶纺锤体蛋白(Eg5)抑制剂,IC50为2 nM。 | ||||
| GC73031 | Salpyran dihydrochloride | - | >99.00% | |
Salpyran dihydrochloride是一种具有治疗潜力的Cu(II)选择性螯合剂。 | ||||
| GC73060 | NOTA-FAPI | 2374782-03-1 | >99.00% | |
NOTA-FAPI是一种成纤维细胞活化蛋白(FAP)抑制剂。 | ||||
| GC73077 | ARI-1 | - | >99.00% | |
ARI-1是受体酪氨酸激酶样孤儿受体1 (ROR1)抑制剂的抑制剂。 | ||||
| GC73093 | Custirsen sodium | - | >98.00% | |
Custirsen sodium抑制簇集蛋白的产生,簇集蛋白是一种抗凋亡蛋白,在化疗后上调,并赋予治疗耐药性。 | ||||
| GC73098 | STING agonist-17 | 2816929-47-0 | >96.00% | |
STING agonist-17(化合物4a)是一种有效的STING激动剂,IC50值为0.062 nM。 | ||||
| GC73106 | Cemdisiran sodium | - | >96.00% | |
Cemdisiran sodium是一种N-乙酰半乳糖胺(GalNAc)偶联的siRNA,用于通过抑制肝脏产生补体5(C5)蛋白来研究补体介导的疾病。 | ||||
| GC73109 | Danvatirsen sodium | - | >97.00% | |
Danvatirsen sodium是一种靶向STAT3的反义寡核苷酸,具有潜在的抗肿瘤活性。 | ||||
| GC73112 | JPS014 TFA | - | >98.00% | |
JPS014 TFA是一种基于苯甲酰胺的Von Hippel-Lindau(VHL)E3连接酶蛋白水解靶向嵌合体(PROTAC)。 | ||||
| GC73118 | EB1 | 42951-68-8 | >99.00% | |
EB1是MNK激酶的抑制剂,ic50值分别为0.69 μM (MNK1)和9.4 μM (MNK2)。 | ||||
| GC73126 | FAPI-74 | 2374782-76-8 | >99.00% | |
FAPI-74是一种靶向成纤维细胞活化蛋白(FAP)的PET(正电子发射断层扫描)示踪剂。 | ||||
| GC73129 | SIAIS164018 hydrochloride | - | >99.00% | |
SIAIS164018 hydrochloride是一种基于protac的ALK和EGFR降解剂,ALK和ALK G1202R的IC50值分别为2.5 nM和6.6 nM。 | ||||
| GC73133 | Misetionamide | 856785-75-6 | >99.00% | |
Misetionamide是一种口服的类似恶硫嗪的化合物。 | ||||
| GC73135 | Glu-urea-Glu-NHS ester | 1228927-36-3 | >97.00% | |
Glu-urea-Glu-NHS ester是Glu-尿素-Glu的活化N-羟基琥珀酰胺(NHS)酯,可用作与前列腺特异性膜抗原(PSMA)抑制剂连接的药效团。 | ||||
| GC73136 | VPC-70063 | 13571-44-3 | >99.00% | |
VPC-70063是一种强效的Myc-Max抑制剂,抑制Myc-Max转录活性的IC50值为8.9μM。 | ||||
